P-029: 1st line combination treatment with proteasome-inhibitor and zoledronic acid is effective in reducing later fractures in multiple myeloma irrespective of MM bone disease
Nivakoski, Elise, Eskelinen, Veera, Launonen, Kirsi, Kakko, Sakari, Kuusisto, Milla
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2021)
Get full text
Journal Article
First-Line Combination with Proteasome Inhibitor-Based Treatment and Zoledronic Acid Is Effective in Reducing Later Fractures in Multiple Myeloma Irrespective of Multiple Myeloma Bone Disease at Diagnosis
Eskelinen, Veera, Nivakoski, Elise, Launonen, Kirsi, Partanen, Anu, Kakko, Sakari, Kuusisto, Milla E. L.
Published in Hematology reports (06.08.2024)
Published in Hematology reports (06.08.2024)
Get full text
Journal Article